Cognitive Impairment and Metabolite Profile Alterations in the Hippocampus and Cortex of Male and Female Mice Exposed to a Fat and Sugar-Rich Diet are Normalized by Diet Reversal.
anxiety
brain metabolism
diabetes
high-fat
memory
obesity
sucrose
Journal
Aging and disease
ISSN: 2152-5250
Titre abrégé: Aging Dis
Pays: United States
ID NLM: 101540533
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
29
04
2021
accepted:
20
07
2021
entrez:
3
2
2022
pubmed:
4
2
2022
medline:
4
2
2022
Statut:
epublish
Résumé
Diabetes impacts on brain metabolism, structure, and function. Alterations in brain metabolism have been observed in obesity and diabetes models induced by exposure to diets rich in saturated fat and/or sugar and have been linked to memory impairment. However, it remains to be determined whether brain dysfunction induced by obesogenic diets results from permanent brain alterations. We tested the hypothesis that an obesogenic diet (high-fat and high-sucrose diet; HFHSD) causes reversible changes in hippocampus and cortex metabolism and alterations in behavior. Mice were exposed to HFHSD for 24 weeks or for 16 weeks followed by 8 weeks of diet normalization. Development of the metabolic syndrome, changes in behavior, and brain metabolite profiles by magnetic resonance spectroscopy (MRS) were assessed longitudinally. Control mice were fed an ingredient-matched low-fat and low-sugar diet. Mice fed the HFHSD developed obesity, glucose intolerance and insulin resistance, with a more severe phenotype in male than female mice. Relative to controls, both male and female HFHSD-fed mice showed increased anxiety-like behavior, impaired memory in object recognition tasks, but preserved working spatial memory as evaluated by spontaneous alternation in a Y-maze. Alterations in the metabolite profiles were observed both in the hippocampus and cortex but were more distinct in the hippocampus. HFHSD-induced metabolic changes included altered levels of lactate, glutamate, GABA, glutathione, taurine,
Identifiants
pubmed: 35111373
doi: 10.14336/AD.2021.0720
pii: ad-13-1-267
pmc: PMC8782561
doi:
Types de publication
Journal Article
Langues
eng
Pagination
267-283Informations de copyright
Copyright: © 2022 Garcia-Serrano et al.
Déclaration de conflit d'intérêts
Disclosure/conflict of interest The authors declared no potential conflicts of interest with respect to the research, authorship, and publication of this article.
Références
Nutr Neurosci. 2021 Dec;24(12):978-988
pubmed: 31910791
Front Cell Neurosci. 2017 Aug 08;11:235
pubmed: 28848398
Int J Obes (Lond). 2019 Jun;43(6):1295-1304
pubmed: 30301962
J Exp Neurosci. 2019 Oct 17;13:1179069519883580
pubmed: 31765441
Biochim Biophys Acta. 2016 Apr;1862(4):545-555
pubmed: 26826016
Eur J Pharmacol. 2003 Feb 28;463(1-3):3-33
pubmed: 12600700
Neurobiol Aging. 2014 Jul;35(7):1660-8
pubmed: 24560998
NMR Biomed. 2004 Oct;17(6):405-10
pubmed: 15386626
Behav Brain Res. 2018 Jan 15;336:93-98
pubmed: 28866128
Brain Res Mol Brain Res. 2002 Nov 15;107(2):176-82
pubmed: 12487123
eNeuro. 2020 Jan 6;7(1):
pubmed: 31871124
Front Behav Neurosci. 2016 Nov 21;10:225
pubmed: 27917115
Front Neurosci. 2020 Mar 20;14:229
pubmed: 32265637
J Neurochem. 2009 Oct;111(2):368-79
pubmed: 19694901
Sci Rep. 2017 Jul 14;7(1):5391
pubmed: 28710347
J Cereb Blood Flow Metab. 2017 Jul;37(7):2423-2432
pubmed: 27604311
J Neurochem. 2012 May;121(3):407-17
pubmed: 22353009
Behav Brain Res. 2020 Mar 16;382:112470
pubmed: 31917241
Neuroimage. 2012 Jun;61(2):342-62
pubmed: 22227137
Neural Regen Res. 2020 Mar;15(3):394-400
pubmed: 31571647
Transl Psychiatry. 2019 May 10;9(1):141
pubmed: 31076569
J Clin Invest. 2012 Jan;122(1):153-62
pubmed: 22201683
Biosci Rep. 2018 Sep 7;38(5):
pubmed: 30104398
Front Neuroenergetics. 2009 Oct 12;1:6
pubmed: 20027232
Neuropharmacology. 2018 Jul 1;136(Pt B):223-242
pubmed: 29471055
J Magn Reson Imaging. 2018 Jan 26;:
pubmed: 29377412
J Cereb Blood Flow Metab. 2021 Jul;41(7):1734-1743
pubmed: 32757742
PLoS One. 2013 Jul 23;8(7):e69782
pubmed: 23936100
Int J Obes (Lond). 2020 Oct;44(10):2080-2091
pubmed: 32796919
Neurochem Res. 2003 Jun;28(6):941-53
pubmed: 12718449
J Cereb Blood Flow Metab. 2010 Aug;30(8):1527-37
pubmed: 20424632
J Cereb Blood Flow Metab. 2021 Sep;41(9):2356-2369
pubmed: 33730932
MAGMA. 2018 Apr;31(2):341-354
pubmed: 29027041
Nat Neurosci. 2021 Apr;24(4):489-503
pubmed: 33603230
Cell Metab. 2017 Jul 5;26(1):185-197.e3
pubmed: 28683286
Hypertension. 2021 Jul;78(1):195-209
pubmed: 33993723
FEBS J. 2013 Jun;280(12):2806-16
pubmed: 23506295
Brain Res. 2009 Mar 3;1258:25-33
pubmed: 19138677
Eur J Neurol. 2006 Dec;13(12):1385-8
pubmed: 17116226
Neurochem Res. 2005 Dec;30(12):1615-21
pubmed: 16362781
Front Neurosci. 2019 Jan 09;12:1015
pubmed: 30686981
Front Neurosci. 2019 Jan 08;12:985
pubmed: 30670942
Ageing Res Rev. 2010 Oct;9(4):399-417
pubmed: 20444434
Neurotox Res. 2019 Aug;36(2):268-278
pubmed: 28971314
PLoS One. 2013 Jun 03;8(6):e66069
pubmed: 23755298
J Biomed Sci. 2010 Aug 24;17 Suppl 1:S23
pubmed: 20804598
Mol Cell Endocrinol. 2018 Jan 15;460:238-245
pubmed: 28760600
Int J Neuropsychopharmacol. 2015 Oct 03;19(3):pyv110
pubmed: 26433393
Diabetes Care. 2013 Jun;36(6):1554-61
pubmed: 23275366
PLoS One. 2012;7(4):e21899
pubmed: 22514596
Nutr Metab (Lond). 2019 Aug 23;16:57
pubmed: 31462902
Front Neurosci. 2021 Jan 18;14:604150
pubmed: 33536868